CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Black Diamond Therapeutics, Inc. (BDTX) on Tuesday reported a loss of $19.9 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 36 cents.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
Black Diamond shares have climbed 89% since the beginning of the year. The stock has climbed 49% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BDTX at https://www.zacks.com/ap/BDTX
